The Company has a team of Quality Assurance specialists handling the QA department in order to guarantee the optimum implementation of ISO and GMP standards. Setting and implementing qualification and validation plans is a critical part of the work of the QA team in order to ensure quality, safety and effectiveness of machines, products and processes. Documentation of all policies, tasks, protocols, and validation reports are considered as vital for attaining performance adequacy and authorization at Oubari. The QA team is supplemented with regular training and external assessments from international experts allowing it to maintain the stated quality level and criticality of production.
R&D is also an essential block in Oubari’s strategic development and sustainability plans. Since 2000, Oubari Pharma employs a team of R&D researchers and scientists as an independent department focusing on producing generic description and references for control, stability and manufacturing analysis.
Oubari Pharma was among the first Pharmaceutical Enterprises in Syria to achieve ISO 14001:2004 for environment, OHSAS 18001:2007 for safety, and ISO 9001:2008 for quality management. We are steadily working to achieve European GMP and FDA compliance and are regularly monitored by Syrian and European auditing parties.
